Iron in the brain

Hyperfine Interactions

Volumn 189, Issue 1-3, 2009, Pages 31-37

  Galazka Friedman, Jolanta ^a   Friedman, Andrzej ^b   Bauminger, Erika R ^c  

^a WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Electron microscopy; ELISA; Human brain iron; M ssbauer spectroscopy; Parkinson's disease

Indexed keywords

EID: 67349200202     PISSN: 03043843     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10751-009-9926-7     Document Type: Article

References (23)

1. B Hallgren P Sourander 1958 The effect of age on the non-haemin iron the human brain J. Neurochem. 3 41 51
2. WR Martin FQ Ye PS Allen 1998 Increasing striatal iron content associated with normal aging Mov. Disord. 13 281 286 (Pubitemid 28127804)
3. J Gała̧zka-Friedman A Friedman 1997 Controversies about iron in parkinsonian and control substantia nigra Acta Neurobiol. Exp. 57 210 225
4. ER Bauminger M Barcikowska A Friedman J Gała̧zka-Friedman D Hechel I Nowik 1994 Does iron play a role in Parkinson's disease? Hyperfine Interact. 91 853 856
5. J Gała̧zka-Friedman ER Bauminger A Friedman M Barcikowska D Hechel I Nowik 1996 Iron in parkinsonian and control substantia nigra-a Mössbauer spectroscopy study Mov. Disord. 11 8 16
6. J Gała̧zka-Friedman ER Bauminger T Tymosz A Friedman 1998 Mössbauer spectroscopy, electron microscopy and electron diffraction studies of ferritin-like iron in human heart, liver and brain Hyperfine Interact. (C)3 49 52
7. A Friedman J Gała̧zka-Friedman 2001 The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress Adv. Neurol. 86 137 142
8. J Galazka-Friedman ER Bauminger A Friedman 2002 Iron in Parkinson's disease-revisited Hyperfine Interact. 141/142 267 271
9. J Galazka-Friedman ER Bauminger D Koziorowski A Friedman 2004 Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra Biochim. Biophys. Acta 1688 130 136 (Pubitemid 38264407)
10. J Galazka-Friedman ER Bauminger A Friedman D Koziorowski K Szlachta 2005 Human nigral and liver iron-comparison by Mössbauer spectroscopy, electron microscopy and ELISA Hyperfine Interact. 165 285 288
11. M Gerlach AX Trautwein L Zecca MBH Youdim P Riederer 1995 Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra J. Neurochem. 65 923 926
12. L Zecca M Gallorini V Schuenemann AX Trautwein M Gerlach P Riederer P Vezzoni D Tampellini 2001 Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes J. Neurochem. 76 1766 1773 (Pubitemid 32221116)
13. KL Double M Gerlach V Schuenemann AX Trautwein L Zecca M Gallorini MBH Youdim P Riederer D Ben-Shachar 2003 Iron-binding characteristics of neuromelanin of the human substantia nigra Biochem. Pharmacol. 66 489 494 (Pubitemid 36937034)
14. SM Dubiel B Zablotna-Rypien JB Mackey JM Williams 1999 Magnetic properties of human liver and brain ferritin Eur. Biophys. J. 28 263 267 (Pubitemid 29225605)
15. PM Harrison P Arosio 1996 The ferritins: molecular properties, iron storage function and cellular regulation Biochim. Biophys. Acta 1275 161 203 (Pubitemid 26248989)
16. JM Williams SC Andrew A Treffry PM Harrison 1986 The relationship between ferritin and haemosiderin Hyperfine Interact. 29 1447 1450
17. SH Bell MP Weir DP Dickson JF Gibson GA Sharp TJ Peters 1984 Mössbauer spectroscopic studies of human haemosiderin and ferritin Biochim. Biophys. Acta 787 227 236 (Pubitemid 14056179)
18. H Braak E Braak 1991 Neuropathological staging of Alzheimer-related changes Acta Neuropathol. (Berl) 82 239 259
19. K Jellinger E Kienzel G Rumpelmair P Riederer H Stachelberger D Ben-Shachar MBH Youdim 1992 Iron-melanin complex in substantia nigra of parkinsonian brains: an X-ray microanalysis J. Neurochem. 59 1168 1171
20. L Zecca A Stroppolo A Gatti D Tampellini M Toscani M Gallorini G Giaveri P Arosio P Santambrogio RG Fariello E Karatekin MH Kleinman N Torro O Hornykiewicz FA Zucca 2004 The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging Proc. Natl. Acad. Sci. U. S. A. 101 9843 9848 (Pubitemid 38869324)
21. Friedman, A., Galazka-Friedman, J., Bauminger, E.R.: Iron as a trigger of neurodegeneration in Parkinson's disease. In: Koller, W., Melamed, E. (eds.) Handbook of Clinical Neurology, Parkinson's Disease and Related Disorders, vol. 83, pp. 493-506, ISBN 0444519009. Elsevier (2007)
22. Galazka-Friedman, J., Bauminger, E.R., Szlachta, K., Wszolek, Z., Dickson, D., Friedman, A.: Is the substantial increase of iron concentration in parkinsonian substantia nigra a real fact? XLII Zakopane School of Physics International Symposium. Zakopane 2008, Book of abstracts, p. 28 (2008)
23. W Zhu W Xie T Pan P Xu M Fridkin H Zheng J Jankovic MBH Youdim W Le 2007 Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators FASEB J. 21 3835 3844 (Pubitemid 350232341)